"Global U.S. Opioids Market Overview:
Global U.S. Opioids Market is expected to grow at a significant rate during the forecast period 2025-2032, with 2024 as the base year.
Global U.S. Opioids Market Report 2025 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of U.S. Opioids involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the U.S. Opioids Market:
The U.S. Opioids Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for U.S. Opioids Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study U.S. Opioids Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, U.S. Opioids market has been segmented into:
Oxycodone
Hydrocodone
Morphine
Codeine
Methadone
and Others
By Application, U.S. Opioids market has been segmented into:
Pain Management
Cough Treatment
and Diarrhea Treatment
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The U.S. Opioids market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the U.S. Opioids market.
Top Key Players Covered in U.S. Opioids market are:
Pfizer
Inc.
Mallinckrodt Pharmaceuticals
Hikma Pharmaceuticals PLC
Mundipharma International
Boehringer Ingelheim International GmbH.
Collegium Pharmaceutical
Sun Pharmaceutical Industries Ltd.
Jazz Pharmaceuticals
Inc.
Curaleaf
Purdue Pharma L.P.
Cresco Labs
Trulieve
Teva Pharmaceutical Industries Ltd.
Green Thumb Industries
Trevena
Inc.
Par Pharmaceutical
Emergent BioSolutions Inc.
"
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: U.S. Opioids Market by Type
4.1 U.S. Opioids Market Snapshot and Growth Engine
4.2 U.S. Opioids Market Overview
4.3 Oxycodone
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Oxycodone: Geographic Segmentation Analysis
4.4 Hydrocodone
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Hydrocodone: Geographic Segmentation Analysis
4.5 Morphine
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Key Market Trends, Growth Factors and Opportunities
4.5.4 Morphine: Geographic Segmentation Analysis
4.6 Codeine
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.6.3 Key Market Trends, Growth Factors and Opportunities
4.6.4 Codeine: Geographic Segmentation Analysis
4.7 Methadone
4.7.1 Introduction and Market Overview
4.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.7.3 Key Market Trends, Growth Factors and Opportunities
4.7.4 Methadone: Geographic Segmentation Analysis
4.8 and Others
4.8.1 Introduction and Market Overview
4.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.8.3 Key Market Trends, Growth Factors and Opportunities
4.8.4 and Others: Geographic Segmentation Analysis
Chapter 5: U.S. Opioids Market by Application
5.1 U.S. Opioids Market Snapshot and Growth Engine
5.2 U.S. Opioids Market Overview
5.3 Pain Management
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Pain Management: Geographic Segmentation Analysis
5.4 Cough Treatment
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Cough Treatment: Geographic Segmentation Analysis
5.5 and Diarrhea Treatment
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 and Diarrhea Treatment: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 U.S. Opioids Market Share by Manufacturer (2023)
6.1.3 Industry BCG Matrix
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 PFIZER
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Role of the Company in the Market
6.2.5 Sustainability and Social Responsibility
6.2.6 Operating Business Segments
6.2.7 Product Portfolio
6.2.8 Business Performance
6.2.9 Key Strategic Moves and Recent Developments
6.2.10 SWOT Analysis
6.3 INC.
6.4 MALLINCKRODT PHARMACEUTICALS
6.5 HIKMA PHARMACEUTICALS PLC
6.6 MUNDIPHARMA INTERNATIONAL
6.7 BOEHRINGER INGELHEIM INTERNATIONAL GMBH.
6.8 COLLEGIUM PHARMACEUTICAL
6.9 SUN PHARMACEUTICAL INDUSTRIES LTD.
6.10 JAZZ PHARMACEUTICALS
6.11 INC.
6.12 CURALEAF
6.13 PURDUE PHARMA L.P.
6.14 CRESCO LABS
6.15 TRULIEVE
6.16 TEVA PHARMACEUTICAL INDUSTRIES LTD.
6.17 GREEN THUMB INDUSTRIES
6.18 TREVENA
6.19 INC.
6.20 PAR PHARMACEUTICAL
6.21 AND EMERGENT BIOSOLUTIONS INC.
Chapter 7: Global U.S. Opioids Market By Region
7.1 Overview
7.2. North America U.S. Opioids Market
7.2.1 Key Market Trends, Growth Factors and Opportunities
7.2.2 Top Key Companies
7.2.3 Historic and Forecasted Market Size by Segments
7.2.4 Historic and Forecasted Market Size By Type
7.2.4.1 Oxycodone
7.2.4.2 Hydrocodone
7.2.4.3 Morphine
7.2.4.4 Codeine
7.2.4.5 Methadone
7.2.4.6 and Others
7.2.5 Historic and Forecasted Market Size By Application
7.2.5.1 Pain Management
7.2.5.2 Cough Treatment
7.2.5.3 and Diarrhea Treatment
7.2.6 Historic and Forecast Market Size by Country
7.2.6.1 US
7.2.6.2 Canada
7.2.6.3 Mexico
7.3. Eastern Europe U.S. Opioids Market
7.3.1 Key Market Trends, Growth Factors and Opportunities
7.3.2 Top Key Companies
7.3.3 Historic and Forecasted Market Size by Segments
7.3.4 Historic and Forecasted Market Size By Type
7.3.4.1 Oxycodone
7.3.4.2 Hydrocodone
7.3.4.3 Morphine
7.3.4.4 Codeine
7.3.4.5 Methadone
7.3.4.6 and Others
7.3.5 Historic and Forecasted Market Size By Application
7.3.5.1 Pain Management
7.3.5.2 Cough Treatment
7.3.5.3 and Diarrhea Treatment
7.3.6 Historic and Forecast Market Size by Country
7.3.6.1 Bulgaria
7.3.6.2 The Czech Republic
7.3.6.3 Hungary
7.3.6.4 Poland
7.3.6.5 Romania
7.3.6.6 Rest of Eastern Europe
7.4. Western Europe U.S. Opioids Market
7.4.1 Key Market Trends, Growth Factors and Opportunities
7.4.2 Top Key Companies
7.4.3 Historic and Forecasted Market Size by Segments
7.4.4 Historic and Forecasted Market Size By Type
7.4.4.1 Oxycodone
7.4.4.2 Hydrocodone
7.4.4.3 Morphine
7.4.4.4 Codeine
7.4.4.5 Methadone
7.4.4.6 and Others
7.4.5 Historic and Forecasted Market Size By Application
7.4.5.1 Pain Management
7.4.5.2 Cough Treatment
7.4.5.3 and Diarrhea Treatment
7.4.6 Historic and Forecast Market Size by Country
7.4.6.1 Germany
7.4.6.2 UK
7.4.6.3 France
7.4.6.4 Netherlands
7.4.6.5 Italy
7.4.6.6 Russia
7.4.6.7 Spain
7.4.6.8 Rest of Western Europe
7.5. Asia Pacific U.S. Opioids Market
7.5.1 Key Market Trends, Growth Factors and Opportunities
7.5.2 Top Key Companies
7.5.3 Historic and Forecasted Market Size by Segments
7.5.4 Historic and Forecasted Market Size By Type
7.5.4.1 Oxycodone
7.5.4.2 Hydrocodone
7.5.4.3 Morphine
7.5.4.4 Codeine
7.5.4.5 Methadone
7.5.4.6 and Others
7.5.5 Historic and Forecasted Market Size By Application
7.5.5.1 Pain Management
7.5.5.2 Cough Treatment
7.5.5.3 and Diarrhea Treatment
7.5.6 Historic and Forecast Market Size by Country
7.5.6.1 China
7.5.6.2 India
7.5.6.3 Japan
7.5.6.4 South Korea
7.5.6.5 Malaysia
7.5.6.6 Thailand
7.5.6.7 Vietnam
7.5.6.8 The Philippines
7.5.6.9 Australia
7.5.6.10 New Zealand
7.5.6.11 Rest of APAC
7.6. Middle East & Africa U.S. Opioids Market
7.6.1 Key Market Trends, Growth Factors and Opportunities
7.6.2 Top Key Companies
7.6.3 Historic and Forecasted Market Size by Segments
7.6.4 Historic and Forecasted Market Size By Type
7.6.4.1 Oxycodone
7.6.4.2 Hydrocodone
7.6.4.3 Morphine
7.6.4.4 Codeine
7.6.4.5 Methadone
7.6.4.6 and Others
7.6.5 Historic and Forecasted Market Size By Application
7.6.5.1 Pain Management
7.6.5.2 Cough Treatment
7.6.5.3 and Diarrhea Treatment
7.6.6 Historic and Forecast Market Size by Country
7.6.6.1 Turkey
7.6.6.2 Bahrain
7.6.6.3 Kuwait
7.6.6.4 Saudi Arabia
7.6.6.5 Qatar
7.6.6.6 UAE
7.6.6.7 Israel
7.6.6.8 South Africa
7.7. South America U.S. Opioids Market
7.7.1 Key Market Trends, Growth Factors and Opportunities
7.7.2 Top Key Companies
7.7.3 Historic and Forecasted Market Size by Segments
7.7.4 Historic and Forecasted Market Size By Type
7.7.4.1 Oxycodone
7.7.4.2 Hydrocodone
7.7.4.3 Morphine
7.7.4.4 Codeine
7.7.4.5 Methadone
7.7.4.6 and Others
7.7.5 Historic and Forecasted Market Size By Application
7.7.5.1 Pain Management
7.7.5.2 Cough Treatment
7.7.5.3 and Diarrhea Treatment
7.7.6 Historic and Forecast Market Size by Country
7.7.6.1 Brazil
7.7.6.2 Argentina
7.7.6.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
U.S. Opioids Scope:
|
Report Data
|
U.S. Opioids Market
|
|
U.S. Opioids Market Size in 2025
|
USD XX million
|
|
U.S. Opioids CAGR 2025 - 2032
|
XX%
|
|
U.S. Opioids Base Year
|
2024
|
|
U.S. Opioids Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Pfizer, Inc., Mallinckrodt Pharmaceuticals, Hikma Pharmaceuticals PLC, Mundipharma International, Boehringer Ingelheim International GmbH., Collegium Pharmaceutical, Sun Pharmaceutical Industries Ltd., Jazz Pharmaceuticals, Inc., Curaleaf, Purdue Pharma L.P., Cresco Labs, Trulieve, Teva Pharmaceutical Industries Ltd., Green Thumb Industries, Trevena, Inc., Par Pharmaceutical, and Emergent BioSolutions Inc..
|
|
Key Segments
|
By Type
Oxycodone
Hydrocodone
Morphine
Codeine
Methadone
and Others
By Applications
Pain Management
Cough Treatment
and Diarrhea Treatment
|
